2015
DOI: 10.1016/j.jcrs.2014.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Reviewing the reviewers: Appraisal of the United States Veterans Health Administration report on femtosecond laser–assisted cataract surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…However, in their analysis in relation to unilateral or bilateral stenting to palliate malignant hilar obstruction, their conclusions are not fully supported by the data provided. Their data for bilateral or unilateral hilar stenting are derived from 7 studies, 3 of which are fairly dated (Chang et al, 2 De Palma et al, 3 and Freeman and Overby 4 ) and provide their 30-day mortality data (Chang et al 2 and De Palma et al 3 ). There is no difference in the rates of adverse events between the 2 groups, and stent patency and survival were greater with bilateral stenting in more recent studies within the subset where this outcome data is available (Naitoh et al 5 and Liberato and Canena 6 ).…”
Section: Hilar Stenting For Malignant Biliary Obstructionmentioning
confidence: 99%
“…However, in their analysis in relation to unilateral or bilateral stenting to palliate malignant hilar obstruction, their conclusions are not fully supported by the data provided. Their data for bilateral or unilateral hilar stenting are derived from 7 studies, 3 of which are fairly dated (Chang et al, 2 De Palma et al, 3 and Freeman and Overby 4 ) and provide their 30-day mortality data (Chang et al 2 and De Palma et al 3 ). There is no difference in the rates of adverse events between the 2 groups, and stent patency and survival were greater with bilateral stenting in more recent studies within the subset where this outcome data is available (Naitoh et al 5 and Liberato and Canena 6 ).…”
Section: Hilar Stenting For Malignant Biliary Obstructionmentioning
confidence: 99%